Clinical pharmacologists are ambassadors of pharmacogenetics: highlights from the ClinPharm-Expert 2026 congress

The article presents the key decisions and priority directions for the development of the specialty "Clinical Pharmacology" adopted following the congress of Clinical Pharmacologists "ClinPharm-Expert 2026," held on May 21–22, 2026 in Moscow within the framework of the IV Russian Congress "Pharmacotherapy Safety 360°: Noli nocere!" The document summarizes the main provisions of the congress Resolution, which specifies the pathways for implementing the Healthcare Development Strategy of the Russian Federation until 2030. Special attention is given to strengthening the role of clinical pharmacologists as key ambassadors of personalized medicine technologies, including pharmacogenetic testing and therapeutic drug monitoring. The Resolution formulates 19 organizational and educational measures aimed at updating the regulatory framework, integrating clinical pharmacologist consultations into the clinical-statistical groups system, developing networking educational programs, establishing a National Research Center for Clinical Pharmacology, and enhancing the prestige of the specialty ahead of its 30th anniversary in 2027. The article also highlights the inclusion of the journal "Pharmacogenetics and Pharmacogenomics" in the Scopus database and the "White List" of scientific periodicals. The article is intended for clinical pharmacologists, healthcare administrators, physicians of related specialties, and professionals in personalized medicine.